Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Elekta to highlight Precision Radiation Medicine solutions that improve patient outcomes at ASTRO Annual Meeting

CHICAGO, September 3, 2019 – At the American Society for Radiation Oncology (ASTRO) 2019 Annual Meeting, September 15-18 in Chicago, Elekta (EKTA-B.ST) will highlight its growing portfolio of innovative solutions that are making Precision Radiation Medicine the new standard in value-based healthcare. Recent product introductions, including MOSAIQ® Plaza and Elekta Unity MR-Linac, as well as continued advances to the family of HD linear accelerators and MR-guided brachytherapy, demonstrate Elekta’s continued commitment to advancing oncology care. Features in the new solutions include

NPRO: Changes to the board of Norwegian Property ASA

Kjell Sagstad has informed the chair of the board in Norwegian Property ASA (NPRO) that he wants to resign from the board of the company.  Sagstad is Senior Director and Chief Investment Officer of the real estate private equity firm NIAM and the manager of NIAM's Norwegian business. Following NIAM's disposal of all NPRO shares, Kjell Sagstad chose to withdraw from the board in September 2019. Sagstad has been a board member in Norwegian Property ASA since April 2016.  For further information, please contact: Merete Haugli, chair of the board, tel +(47) 99 60 7000

Edgeware launches StreamPilot for unique multi-CDN control

Cloud-based platform enables real-time, in-session and per segment-based delivery control in multi-CDN environments, independent of client, CDN and video formats.Stockholm, Sweden – September 3, 2019 – Edgeware  has today announced the launch of its new StreamPilot  session control platform that will give broadcasters, content providers, and telecom and cable operators real-time, in-session and per segment delivery control when streaming media in a multi-CDN environment. The SaaS-based StreamPilot

For use in demanding applications, COSEL’s very high reliability 80W DC/DC converter comes with 10 year warranty

• 10 year warranty• 80W in 2x1 inch industry footprint, metal case potted• Soft switching, synchronous rectification and efficiency up to 94%• Ultra wide input voltage range (4:1) covered by two series from 9V to 76V• Approved to UL62368-1, C-UL [CSA62368-1) and EN62368-1 Cosel Co, Ltd (6905: Tokyo) today announced the release of a very high reliability 80W DC/DC converter, the MGF80. Packaged in an industry standard 2x1 inch, six sided, shielded metallic case, the MGF80 series has been designed to Cosel’s strict criteria for high performance and reliability, contributing to the

Tele2 files Form 15F and deregisters with the SEC

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) announces that it will file a Form 15F and deregister from the United States Securities and Exchange Commission (“SEC”).To reduce financial reporting complexity and administrative costs, Tele2 will today voluntarily file a Form 15F with the SEC to terminate its reporting obligations under Section 15(d) of the US Securities Exchange Act of 1934. Upon filing Form 15F, Tele2’s reporting obligations will be immediately suspended and the deregistration will be effective 90 days after the filing. Tele2’s shares will continue

Positive feedback from FDA significantly benefits ongoing NefIgArd pivotal Phase 3 study

Calliditas Therapeutics AB (publ) (“Calliditas”) today announced that it has obtained written feedback from the US Food and Drug Administration (FDA) that will have a significant impact on the ongoing pivotal Phase 3 study, NefIgArd, with Calliditas’ leading drug candidate Nefecon for the chronic autoimmune kidney disease IgA Nephropathy (IgAN).Calliditas has had an active dialogue with the FDA around the NefIgArd study during the year and has received acceptance of a design change of the Part B of the NefIgArd study, which significantly simplifies and enhances the design of the

RhoVac optimizes the structure of the management team and appoints Anders Månsson as new CEO

Today, 2nd September 2019, RhoVac AB ("RhoVac") reports that the Board has decided to change the structure of the management group and appoints former deputy Chief Executive Officer, Anders Månsson, as new CEO of RhoVac as of today. Former CEO Anders Ljungqvist remains in the management team as the Chief Operating Officer (COO) with primary responsibility for the implementation of the company's clinical studies and for the further development of CMC. The management team consists of Anders Månsson (CEO), Anders Ljungqvist (COO) and Henrik Stage (CFO). The change in the management team reflects

QuickCool AB (publ): QuickCool AB requests an extra tranche of convertible loan from European High Growth Opportunities Securitization Fund

QuickCool AB (Publ) ("QuickCool" or the "Company") requests an extra tranche of convertible loan amounting to SEK 2 M from European High Growth Opportunities Securitization Fund in accordance with the financing solution announced by Quickcool through a press release on 21 June 2018.Convertible Instruments The board has resolved, based on the general meeting’s authorization, to request the issuance of an extra tranche of convertible loan amounting to SEK 2 million by issuing convertible instruments. The convertible instruments can be converted into shares of QuickCool. European High

Announcement

Kongsberg Automotive (OSE: KOA) announced today that Chief Executive Officer Henning Jensen will present at the J.P. Morgan 2019 European High Yield & Leveraged Finance Conference in London on Wednesday September 4th, 2019 at 9:40 BST. The presentation will include an outlook for FY 2019. This presentation will be posted on the company’s website http://www.kongsbergautomotive.com/ prior to the presentation. About Kongsberg Automotive Kongsberg Automotive provides world-class products to the global vehicle industry. Kongsberg Automotive’s business has a global presence. With revenues

Ossur Hf : Transactions in relation to share buyback program

Announcement no. 50/20192 September 2019  Transactions in relation to share buyback program On 14 May 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 31/2019. The purpose of the share buyback program is to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. The program will end no later than 31 December 2019. The Company may purchase up to 5,000,000 shares under the program, corresponding to 1.2% of the current share capital.

Contemplated sale of shares in Catena AB

2 September 2019 THIS DOCUMENT IS FOR THE USE OF THE INTENDED RECIPIENT ONLY AND SHOULD NOT BE COPIED OR DISTRIBUTED TO ANY OTHER PERSON. NOT FOR DISTRIBUTION IN OR INTO THE U.S. (OR TO U.S.PERSONS) ABSENT REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER U.S. SECURITIES ACT OF 1933, AS AMENDED, OR IN ANY OTHER JURISDICTION IF SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF APPLICABLE SECURITIES LAWS.ABG Sundal Collier has been engaged by Endicott Sweden AB, a wholly owned subsidiary of CLS Holdings plc

Hansa Biopharma: Issue and re-purchase of class C shares for incentive programme

Lund, Sweden September 2, 2019. Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that by virtue of the authorisation by the annual general meeting held on 22 May 2019, the board of directors of Hansa Biopharma AB (publ) has resolved to issue and immediately thereafter re-purchase 715,910 class C shares. The shares are issued and re-purchased in accordance with the incentive programme LTIP 2019, which was adopted by the annual general meeting held on 22 May 2019. Carnegie Investment Bank AB (publ) will subscribe for the

#19-1030 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Purchase of shares for the employee incentive program

Reference is made to Ocean Yield ASA’s (“Ocean Yield” or “Company”) stock exchange notice on 27 August 2019 where the Company announced its intention to purchase up to 150,000 treasury shares in connection with its incentive scheme for employees. Ocean Yield has on 2 September 2019 purchased 37,500 shares in the Company on Oslo Stock Exchange at an average price of NOK 51.4105 per share, which implies a total consideration of NOK 1,927,894. The purchase of treasury shares was carried out in accordance with an authorization granted by the Annual General Meeting of the Company on 25 April

Vestas receives 60 MW order for two merchant projects in Finland with 30-year service contract

News release from Vestas Northern and Central EuropeHamburg, 2 September 2019 Vestas has secured an order from the Nordic developer OX2 backed by the UK investor Infracapital for the wind projects Kröpuln and Storbacken in Western Finland that will be realised on a merchant basis without any direct financial support. The projects have a total capacity of 60 MW of V150-4.2 MW turbines delivered in Power Optimised Mode to maximise power production based on the sites’ specific wind conditions. The contract includes supply, installation and commissioning of the wind turbines, as well as

Total Voting Rights

2 September 2019 15:00 BST Transparency Directive Voting Rights and Capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 31 August 2019 the issued share capital of AstraZeneca PLC with voting rights is 1,311,882,856 ordinary shares of US$0.25. No shares are held in Treasury. Therefore, the total number of voting rights in AstraZeneca PLC is 1,311,882,856. The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which

Proof of Södra’s social responsibility

Södra was top-ranked among companies that assume the greatest corporate social responsibility. This was shown in the world’s largest employer branding survey.“We play an important role in the communities in which we operate and assume great responsibility for both society and the environment. It is gratifying to receive this recognition for our hard work,” said Maria Baldin, Södra’s Director of Communications and Sustainability. Södra took second place in the HR services company Randstad’s Employer Brand Research 2019, a survey of 6,200 Swedes conducted by Kantar TNS. According to

Seliro appoints Kajsa Arvidsson as its new CEO

Stockholm, Sweden, September 2, 2019: Seliro today announced the appointment of Kajsa Arvidsson as Chief Executive Officer of the Group.Seliro today announced the appointment of Kajsa Arvidsson as Chief Executive Officer of Seliro Group. Kajsa joins Seliro from Nokia, where she headed up Marketing and Communication for region Europe. “We are delighted to welcome Kajsa to Seliro” says Johnny Sommarlund, Chairman of the Board. “The group has developed a very attractive portfolio for actors addressing the connected home, and Kajsa brings a wealth of knowledge and experience crucial to scale

Outokumpu’s Shareholders’ Nomination Board composition

Outokumpu OyjStock exchange releaseSeptember 2, 2019 at 4.00 pm EEST Outokumpu’s Shareholders’ Nomination Board composition Outokumpu’s Shareholders’ Nomination Board consists of the representatives of the four largest shareholders registered in the shareholder register of the company following Nasdaq Helsinki’s last trading day in August. In addition, Kari Jordan, Outokumpu’s Chairman of the Board of Directors, acts as an expert member in the Nomination Board. The Nomination Board has been established to annually prepare proposals on the composition of the Board of Directors and

Resolutions of the Extraordinary General Meeting of EVRY ASA

Tieto Corporation        STOCK EXCHANGE RELEASE         2 September 2019, 3.45 pm EET NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF THE LOCAL SECURITIES LAWS OR REGULATIONS OF SUCH JURISDICTION. Resolutions of the Extraordinary General Meeting of EVRY ASA Following the announcement on 26 June 2019 concerning the merger plan between EVRY ASA ("EVRY") and Tieto Corporation ("Tieto"), an extraordinary general meeting of EVRY ASA

Number of trades by Nordnet’s customers in August

In August, 2,472,140 trades were made in stocks, warrants and options among Nordnet’s customers in Sweden, Norway, Denmark and Finland. That corresponds to 112,370 trades on average per day.Table: Nordnet’s total trades on all exchanges and market places for all customers, and average number of trades per day. Average number of trades per day is calculated as total trades divided by the number of days the Swedish exchanges are open.   August August Change  July Change   2019 2018 one 2019 one

EVRY ASA: Shareholders approve merger with Tieto Corporation

Bærum, Norway (2 September 2019) - Following the announcement on 26 June 2019 concerning the merger plan between EVRY ASA ("EVRY") and Tieto Corporation ("Tieto"), an extraordinary general meeting of EVRY ASA was held today at EVRY ASA's premises at Snarøyveien 30A, 1360 Fornebu, Norway at 13:00 CET. All resolutions proposed were approved by the shareholders of EVRY. The minutes from the extraordinary general meeting are attached to this announcement. The shareholders of Tieto will consider the merger at an extraordinary general meeting tomorrow, 3 September 2019. Completion of the

Strong growth and stable result

Net sales in the second quarter of 2019 increased by almost 20 per cent to SEK 693 million (581). Organic growth was 6 percent, and underlying earnings generation remained high. Adjusted EBITA earnings1 increased by almost 20 percent to SEK 46 million (39), corresponding to a margin of 6.6 percent (6.6). Order intake increased by more than 40 percent and amounted to SEK 863 million (SEK 606 million).“Our good profitability is the result of a specialized offer, a limited risk profile as well as competent employees and close cooperation with our customers and partners. We see a continued good

The neurobiological mechanisms behind schizophrenia may depend on gender

The neurobiological pathophysiology of schizophrenia differs significantly between males and females, according to a new study. The findings suggest a possible need for more sex-specific treatments for schizophrenia. The study was the first to identify a number of sex-specific genes related to schizophrenia using neurons derived from induced pluripotent stem cells. The results were published in Nature Communications. Co-ordinated by the University of Eastern Finland, the University of Helsinki and Karolinska Institutet, the study investigated the differences in gene and protein

There are no items matching the current filter
There are no more items matching the current filter
Back to top